{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:40:03Z","timestamp":1774899603035,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"],"award-info":[{"award-number":["(JIP\/Dean(R)\/Intramural\/Phs 1\/2019-20)"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Podocytopathies, including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and collapsing glomerulopathy (CG), are kidney diseases that damage glomerular podocytes, leading to heavy proteinuria and nephrotic syndrome (NS). Inflammation plays a critical role in the progression of chronic kidney disease (CKD), with recent studies linking inflammatory biomarkers to declining kidney function. Tumor necrosis factor-alpha (TNF-\u03b1), an essential inflammatory cytokine, interacts with its circulating receptors, TNFR1 and TNFR2. The TNF-\u03b1 pathway has been implicated in the pathogenesis of FSGS and MCD. Increased circulating TNFR2 levels have been associated with worsening renal function in podocytopathies, suggesting that the TNF-\u03b1 inflammatory pathway significantly contributes to disease progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a study involving 53 patients with biopsy-proven MCD or FSGS and 53 healthy, age- and gender-matched controls. All patients were followed for 18\u00a0months. We analyzed serum and urine TNFR2 levels and gene expression at baseline and after three months. To assess the ability of TNFR2 to predict persistent decline in estimated glomerular filtration rate (eGFR\u2009&lt;\u200930\u00a0mL\/min\/1.73m<jats:sup>2<\/jats:sup>), remission, and relapse, we employed Cox regression analysis. Additionally, we evaluated its prognostic utility for predicting progression to stage 4 CKD using ROC curve analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum and urine TNFR2 levels were significantly elevated in patients compared to controls. Serum TNFR2 was a significant predictor in univariate Cox regression analysis for persistent eGFR decline (HR 1.017, 95% CI: 1.003 to 1.032, <jats:italic>p<\/jats:italic>\u2009=\u20090.018), remission (HR 0.995, 95% CI: 0.992 to 0.999, <jats:italic>p<\/jats:italic>\u2009=\u20090.006), and relapse (HR 1.005, 95% CI: 1.001 to 1.010, <jats:italic>p<\/jats:italic>\u2009=\u20090.029). The ROC curve analysis demonstrated that serum TNFR2 levels had a strong prognostic ability for predicting progression to stage 4 CKD, with an AUC of 0.848 (95% CI: 0.737\u20140.960), sensitivity of 81%, and specificity of 71%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study underscores the critical role of circulating TNFR2 in kidney injury among patients with primary podocytopathy. Elevated TNFR2 levels are significant predictors of persistent eGFR decline and disease relapse, highlighting their potential as biomarkers for disease progression and prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03772-y","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T09:52:10Z","timestamp":1729849930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of baseline soluble tumor necrosis factor receptor 2 as a biomarker in primary podocytopathy: Implications for renal impairment and disease progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Srinivas","family":"Nagaram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadav","family":"Nisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norton","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandeesha","family":"Hanumanthappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejith","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palanivel","family":"Chinnakali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Nachiappa Ganesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"3772_CR1","first-page":"38","volume":"13","author":"R Ramachandran","year":"2021","unstructured":"Ramachandran R, Trivedi M. Treatment of adult podocytopathy: uncharted territory. Kidney News. 2021;13:38\u20139.","journal-title":"Kidney News"},{"key":"3772_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2215\/CJN.04121206","volume":"2","author":"L Barisoni","year":"2007","unstructured":"Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2:529\u201342.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3772_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/ndt\/gfae025","volume":"39","author":"S Mirioglu","year":"2024","unstructured":"Mirioglu S, Daniel-Fischer L, Berke I, Ahmad SH, Bajema IM, Bruchfeld A, et al. Management of adult patients with podocytopathies: an update from the ERA immunonephrology working group. Nephrol Dial Transplant. 2024;39:569\u201380.","journal-title":"Nephrol Dial Transplant"},{"key":"3772_CR4","doi-asserted-by":"publisher","first-page":"113920","DOI":"10.1016\/j.biopha.2022.113920","volume":"156","author":"E Ahmadian","year":"2022","unstructured":"Ahmadian E, Eftekhari A, Atakishizada S, Valiyeva M, Ardalan M, Khalilov R, et al. Podocytopathy: the role of actin cytoskeleton. Biomed Pharmacother. 2022;156:113920.","journal-title":"Biomed Pharmacother"},{"key":"3772_CR5","unstructured":"Guruswamy Sangameswaran KD, Hashmi MF, Baradhi KM. Focal segmental glomerulosclerosis. StatPearls. Treasure Island: StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532272\/. [cited 2024 Jan 31]."},{"key":"3772_CR6","doi-asserted-by":"publisher","first-page":"e0216426","DOI":"10.1371\/journal.pone.0216426","volume":"14","author":"C-F Chung","year":"2019","unstructured":"Chung C-F, Kitzler T, Kachurina N, Pessina K, Babayeva S, Bitzan M, et al. Intrinsic tumor necrosis factor-\u03b1 pathway is activated in a subset of patients with focal segmental glomerulosclerosis. PLoS One. 2019;14:e0216426.","journal-title":"PLoS ONE"},{"key":"3772_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jdi.13351","volume":"12","author":"T Gohda","year":"2021","unstructured":"Gohda T, Kamei N, Kubota M, Tanaka K, Yamashita Y, Sakuma H, et al. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function. J Diabetes Investig. 2021;12:382\u20139.","journal-title":"J Diabetes Investig"},{"key":"3772_CR8","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1172\/JCI85939","volume":"126","author":"CE Pedigo","year":"2016","unstructured":"Pedigo CE, Ducasa GM, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, et al. Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. J Clin Invest. 2016;126:3336\u201350.","journal-title":"J Clin Invest"},{"key":"3772_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/biom13030534","volume":"13","author":"I Lousa","year":"2023","unstructured":"Lousa I, Reis F, Viana S, Vieira P, Vala H, Belo L, et al. TNFR2 as a potential biomarker for early detection and progression of CKD. Biomolecules. 2023;13:534.","journal-title":"Biomolecules"},{"key":"3772_CR10","doi-asserted-by":"publisher","first-page":"e0132826","DOI":"10.1371\/journal.pone.0132826","volume":"10","author":"YJ Oh","year":"2015","unstructured":"Oh YJ, An JN, Kim CT, Yang SH, Lee H, Kim DK, et al. Circulating tumor necrosis factor \u03b1 receptors predict the outcomes of human IgA nephropathy: a prospective cohort study. PLoS One. 2015;10:e0132826.","journal-title":"PLoS ONE"},{"key":"3772_CR11","doi-asserted-by":"publisher","first-page":"15302","DOI":"10.1038\/s41598-018-33590-w","volume":"8","author":"N Kamei","year":"2018","unstructured":"Kamei N, Yamashita M, Nishizaki Y, Yanagisawa N, Nojiri S, Tanaka K, et al. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes. Sci Rep. 2018;8:15302.","journal-title":"Sci Rep"},{"key":"3772_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000342333","volume":"36","author":"MM Speeckaert","year":"2012","unstructured":"Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36:261\u201370.","journal-title":"Am J Nephrol"},{"key":"3772_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000072065","volume":"23","author":"MH Cho","year":"2003","unstructured":"Cho MH, Lee HS, Choe BH, Kwon SH, Chung KY, Koo JH, et al. Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability. Am J Nephrol. 2003;23:260\u20136.","journal-title":"Am J Nephrol"},{"key":"3772_CR14","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.3390\/ijms23063284","volume":"23","author":"I Lousa","year":"2022","unstructured":"Lousa I, Reis F, Santos-Silva A, Belo L. The signaling pathway of TNF receptors: linking animal models of renal disease to human CKD. Int J Mol Sci. 2022;23:3284.","journal-title":"Int J Mol Sci"},{"key":"3772_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","volume":"68","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G, Cholesterol and Recurrent Events (CARE) Trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237\u201345.","journal-title":"Kidney Int"},{"key":"3772_CR16","doi-asserted-by":"publisher","first-page":"e104354","DOI":"10.1371\/journal.pone.0104354","volume":"9","author":"SM Lee","year":"2014","unstructured":"Lee SM, Yang S, Cha R, Kim M, An JN, Paik JH, et al. Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy. PLoS One. 2014;9:e104354.","journal-title":"PLoS ONE"},{"key":"3772_CR17","unstructured":"KDIGO-GN-GL-Public-Review-Draft_1-June-2020.pdf. Available from: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO-GN-GL-Public-Review-Draft_1-June-2020.pdf. [cited 2024 Apr 24]."},{"key":"3772_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"3772_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","volume":"91","author":"S Sethi","year":"2017","unstructured":"Sethi S, D\u2019Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int. 2017;91:787\u20139.","journal-title":"Kidney Int"},{"key":"3772_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2011060627","volume":"23","author":"MA Niewczas","year":"2012","unstructured":"Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012;23:507\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"3772_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00011-022-01574-2","volume":"71","author":"I Lousa","year":"2022","unstructured":"Lousa I, Belo L, Valente MJ, Rocha S, Pregui\u00e7a I, Rocha-Pereira P, et al. Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline. Inflamm Res. 2022;71:591\u2013602.","journal-title":"Inflamm Res"},{"key":"3772_CR22","doi-asserted-by":"publisher","first-page":"F945","DOI":"10.1152\/ajprenal.00423.2007","volume":"294","author":"KN Lai","year":"2008","unstructured":"Lai KN, Leung JCK, Chan LYY, Saleem MA, Mathieson PW, Lai FM, et al. Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol. 2008;294:F945\u2013955.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3772_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1681\/ASN.2011060628","volume":"23","author":"T Gohda","year":"2012","unstructured":"Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012;23:516\u201324.","journal-title":"J Am Soc Nephrol"},{"key":"3772_CR24","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.2337\/dc12-2521","volume":"36","author":"MF Lopes-Virella","year":"2013","unstructured":"Lopes-Virella MF, Baker NL, Hunt KJ, Cleary PA, Klein R, Virella G, et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes Care. 2013;36:2317\u201323.","journal-title":"Diabetes Care"},{"key":"3772_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.diabres.2011.01.008","volume":"92","author":"I Miyazawa","year":"2011","unstructured":"Miyazawa I, Araki S, Obata T, Yoshizaki T, Morino K, Kadota A, et al. Association between serum soluble TNF\u03b1 receptors and renal dysfunction in type 2 diabetic patients without proteinuria. Diabetes Res Clin Pract. 2011;92:174\u201380.","journal-title":"Diabetes Res Clin Pract"},{"key":"3772_CR26","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/ndt\/gfq310","volume":"25","author":"I Idasiak-Piechocka","year":"2010","unstructured":"Idasiak-Piechocka I, Oko A, Pawliczak E, Kaczmarek E, Czekalski S. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Nephrol Dial Transplant. 2010;25:3948\u201356.","journal-title":"Nephrol Dial Transplant"},{"key":"3772_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1172\/JCI200523348","volume":"115","author":"V Vielhauer","year":"2005","unstructured":"Vielhauer V, Stavrakis G, Mayadas TN. Renal cell\u2013expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest. 2005;115:1199\u2013209.","journal-title":"J Clin Invest"},{"key":"3772_CR28","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/cells12182214","volume":"12","author":"A Arthanarisami","year":"2023","unstructured":"Arthanarisami A, Komaru Y, Katsouridi C, Schumacher J, Verges DK, Ning L, et al. Acute kidney injury-induced circulating TNFR1\/2 elevations correlate with persistent kidney injury and progression to fibrosis. Cells. 2023;12:2214.","journal-title":"Cells"},{"key":"3772_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/labinvest.3780364","volume":"81","author":"RS Al-Lamki","year":"2001","unstructured":"Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest. 2001;81:1503\u201315.","journal-title":"Lab Invest"},{"key":"3772_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1681\/ASN.2008020156","volume":"19","author":"PG Tipping","year":"2008","unstructured":"Tipping PG. Are podocytes passive or provocative in proteinuric glomerular pathology? J Am Soc Nephrol. 2008;19:651\u20133.","journal-title":"J Am Soc Nephrol"},{"key":"3772_CR31","doi-asserted-by":"publisher","first-page":"761600","DOI":"10.3389\/fmed.2021.761600","volume":"8","author":"S Purohit","year":"2021","unstructured":"Purohit S, Piani F, Ordo\u00f1ez FA, de Lucas-Collantes C, Bauer C, Cara-Fuentes G. Molecular mechanisms of proteinuria in minimal change disease. Front Med (Lausanne). 2021;8:761600.","journal-title":"Front Med (Lausanne)"},{"key":"3772_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fmed.2018.00098","volume":"5","author":"Y Wen","year":"2018","unstructured":"Wen Y, Shah S, Campbell KN. Molecular mechanisms of proteinuria in focal segmental glomerulosclerosis. Front Med (Lausanne). 2018;5:98.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03772-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03772-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03772-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T09:52:32Z","timestamp":1729849952000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03772-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3772"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03772-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Jawaharlal Institute of Postgraduate Medical Education & Research (IEC No. JIP\/IEC\/2019\/070), date: 14.05.2019.Written informed consent was obtained from the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}